These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16834739)

  • 1. Fibrinogen Denver: a dysfibrinogenemia associated with an abnormal Reptilase time and significant bleeding.
    Walter S; Stabler S; Lefkowitz JB
    Haemophilia; 2006 Jul; 12(4):393-7. PubMed ID: 16834739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factor.
    Favaloro EJ; Bonar R; Survela L; McDonald D; Koutts J; Sioufi J; Marsden K
    Lab Hematol; 2007; 13(4):128-34. PubMed ID: 18192144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F; Samama M
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sources of variation in factor VIII, von Willebrand factor and fibrinogen measurements: implications for detecting deficiencies and increased plasma levels.
    Bach J; Haubelt H; Hellstern P
    Thromb Res; 2010 Sep; 126(3):e188-95. PubMed ID: 20627205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated fibrinogen in an acute phase reaction prolongs the reptilase time but typically not the thrombin time.
    Van Cott EM; Smith EY; Galanakis DK
    Am J Clin Pathol; 2002 Aug; 118(2):263-8. PubMed ID: 12162688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new automated screening assay for the diagnosis of von Willebrand disease.
    Salem RO; Van Cott EM
    Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
    Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
    Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory testing for fibrinogen abnormalities.
    Verhovsek M; Moffat KA; Hayward CP
    Am J Hematol; 2008 Dec; 83(12):928-31. PubMed ID: 18951466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-generating capacity in patients with von Willebrand's disease.
    Rugeri L; Beguin S; Hemker C; Bordet JC; Fleury R; Chatard B; Negrier C; Dargaud Y
    Haematologica; 2007 Dec; 92(12):1639-46. PubMed ID: 18055987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U; Pieconka A; Will K; Schneppenheim R
    Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
    Miesbach W; Galanakis D; Scharrer I
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
    Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation.
    Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.